$12.62
0.302.44%
At close: -
$12.62
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Core Laboratories Analyst Ratings and Price Targets | NYSE:CLB | Benzinga
Core Laboratories Inc has a consensus price target of $16.6 based on the ratings of 6 analysts. The high is $20 issued by Morgan Stanley on September 26, 2022. The low is $15 issued by Stifel on April 15, 2025. The 3 most-recent analyst ratings were released by Stifel, Citigroup, and Citigroup on April 15, 2025, March 12, 2025, and February 20, 2025, respectively. With an average price target of $15.33 between Stifel, Citigroup, and Citigroup, there's an implied 21.50% upside for Core Laboratories Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
Citigroup
B of A Securities
Piper Sandler
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Core Laboratories
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/15/2025 | Buy Now | 18.86% | Stifel | Stephen Gengaro48% | $19 → $15 | Maintains | Hold | Get Alert |
| 03/12/2025 | Buy Now | 26.78% | Citigroup | Scott Gruber60% | $15 → $16 | Upgrade | Sell → Neutral | Get Alert |
| 02/20/2025 | Buy Now | 18.86% | Citigroup | Scott Gruber60% | $14 → $15 | Maintains | Sell | Get Alert |
| 10/31/2024 | Buy Now | 10.94% | Citigroup | Scott Gruber60% | $15 → $14 | Maintains | Sell | Get Alert |
| 07/26/2024 | Buy Now | 74.33% | Stifel | Stephen Gengaro48% | $18 → $22 | Maintains | Hold | Get Alert |
| 07/15/2024 | Buy Now | 18.86% | B of A Securities | Chase Mulvehill48% | $16 → $15 | Maintains | Underperform | Get Alert |
| 07/15/2024 | Buy Now | 34.71% | Piper Sandler | Luke Lemoine49% | $18 → $17 | Maintains | Neutral | Get Alert |
| 04/26/2024 | Buy Now | 42.63% | Stifel | Stephen Gengaro48% | $17 → $18 | Maintains | Hold | Get Alert |
| 04/15/2024 | Buy Now | 26.78% | B of A Securities | Chase Mulvehill48% | $17 → $16 | Maintains | Underperform | Get Alert |
| 02/05/2024 | Buy Now | 34.71% | Stifel | Stephen Gengaro48% | $21 → $17 | Maintains | Hold | Get Alert |
| 01/29/2024 | Buy Now | 66.4% | Stifel | Stephen Gengaro48% | $23 → $21 | Maintains | Hold | Get Alert |
| 09/18/2023 | Buy Now | 58.48% | Citigroup | Scott Gruber60% | $21 → $20 | Maintains | Sell | Get Alert |
| 07/31/2023 | Buy Now | 66.4% | Piper Sandler | Luke Lemoine49% | $19 → $21 | Maintains | Neutral | Get Alert |
| 06/30/2023 | Buy Now | 66.4% | Citigroup | Scott Gruber60% | $22 → $21 | Downgrade | Neutral → Sell | Get Alert |
| 05/01/2023 | Buy Now | 50.55% | Piper Sandler | Luke Lemoine49% | $18 → $19 | Maintains | Neutral | Get Alert |
| 04/28/2023 | Buy Now | 98.1% | Stifel | Stephen Gengaro48% | $24 → $25 | Maintains | Hold | Get Alert |
| 04/18/2023 | Buy Now | 70.36% | B of A Securities | Chase Mulvehill48% | → $21.5 | Downgrade | Neutral → Underperform | Get Alert |
| 02/07/2023 | Buy Now | 106.02% | Citigroup | Scott Gruber60% | $21 → $26 | Maintains | Neutral | Get Alert |
| 01/09/2023 | Buy Now | — | B of A Securities | Chase Mulvehill48% | — | Upgrade | Underperform → Neutral | Get Alert |
| 10/07/2022 | Buy Now | — | Citigroup | Scott Gruber60% | — | Upgrade | Sell → Neutral | Get Alert |
| 09/26/2022 | Buy Now | 58.48% | Morgan Stanley | Connor Lynagh58% | → $20 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 08/01/2022 | Buy Now | 58.48% | Morgan Stanley | Connor Lynagh58% | $22 → $20 | Maintains | Equal-Weight | Get Alert |
| 07/13/2022 | Buy Now | 74.33% | Morgan Stanley | Connor Lynagh58% | $32 → $22 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | Buy Now | 153.57% | Morgan Stanley | Connor Lynagh58% | $35 → $32 | Maintains | Equal-Weight | Get Alert |
| 04/18/2022 | Buy Now | 68.78% | Piper Sandler | Ian Macpherson62% | $19.5 → $21.3 | Downgrade | Neutral → Underweight | Get Alert |
FAQ
What is the target price for Core Laboratories (CLB) stock?
The latest price target for Core Laboratories (NYSE:CLB) was reported by Stifel on April 15, 2025. The analyst firm set a price target for $15.00 expecting CLB to rise to within 12 months (a possible 18.86% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Core Laboratories (CLB)?
The latest analyst rating for Core Laboratories (NYSE:CLB) was provided by Stifel, and Core Laboratories maintained their hold rating.
When was the last upgrade for Core Laboratories (CLB)?
The last upgrade for Core Laboratories Inc happened on March 12, 2025 when Citigroup raised their price target to $16. Citigroup previously had a sell for Core Laboratories Inc.
When was the last downgrade for Core Laboratories (CLB)?
The last downgrade for Core Laboratories Inc happened on June 30, 2023 when Citigroup changed their price target from $22 to $21 for Core Laboratories Inc.
When is the next analyst rating going to be posted or updated for Core Laboratories (CLB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Core Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Core Laboratories was filed on April 15, 2025 so you should expect the next rating to be made available sometime around April 15, 2026.
Is the Analyst Rating Core Laboratories (CLB) correct?
While ratings are subjective and will change, the latest Core Laboratories (CLB) rating was a maintained with a price target of $19.00 to $15.00. The current price Core Laboratories (CLB) is trading at is $12.62, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
